Skip to main content
Clinical Trials/JPRN-UMIN000025524
JPRN-UMIN000025524
Completed
Phase 2

A multi-institutional study analyzing effect of a novel lozenge containing polaprezinc for patients treated with high dose chemotherapy followed by hematopoietic stem cell transplantation - A multi-institutional study analyzing effect of polaprezinc lozenge

Gifu University0 sites91 target enrollmentJanuary 4, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Hematological malignancy
Sponsor
Gifu University
Enrollment
91
Status
Completed
Last Updated
2 years ago